Ralf A. Linker

8.1k total citations
71 papers, 2.4k citations indexed

About

Ralf A. Linker is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Ralf A. Linker has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 18 papers in Neurology and 15 papers in Immunology. Recurrent topics in Ralf A. Linker's work include Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (6 papers). Ralf A. Linker is often cited by papers focused on Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (6 papers). Ralf A. Linker collaborates with scholars based in Germany, United States and Switzerland. Ralf A. Linker's co-authors include Ralf Gold, Dominik N. Müller, Markus Kleinewietfeld, Arndt Manzel, Fred Lühder, De-Hyung Lee, Susan E. Erdman, David A. Hafler, Martin Stangel and Anne Waschbisch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature reviews. Immunology.

In The Last Decade

Ralf A. Linker

67 papers receiving 2.3k citations

Peers

Ralf A. Linker
De-Hyung Lee Germany
Liqun Yang China
Marjan Gharagozloo Iran
Magnus Andersson Sweden
Hideto Yonekura Japan
Takuo Watanabe Japan
Lucia Lisi Italy
Abdullah Al Mamun China
Mark A. Lovell United States
Osman Yılmaz Türkiye
De-Hyung Lee Germany
Ralf A. Linker
Citations per year, relative to Ralf A. Linker Ralf A. Linker (= 1×) peers De-Hyung Lee

Countries citing papers authored by Ralf A. Linker

Since Specialization
Citations

This map shows the geographic impact of Ralf A. Linker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf A. Linker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf A. Linker more than expected).

Fields of papers citing papers by Ralf A. Linker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf A. Linker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf A. Linker. The network helps show where Ralf A. Linker may publish in the future.

Co-authorship network of co-authors of Ralf A. Linker

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf A. Linker. A scholar is included among the top collaborators of Ralf A. Linker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf A. Linker. Ralf A. Linker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Freudenstein, D., et al.. (2025). Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences. 475. 123577–123577. 1 indexed citations
3.
Peters, Nils, Annaelle Zietz, G. Hubert, et al.. (2023). Clinical Course and Recurrence in Transient Global Amnesia: A Study From the TEMPiS Telestroke Network. Journal of Clinical Neurology. 19(6). 530–530. 3 indexed citations
4.
Linker, Ralf A. & Ralf Gold. (2021). Immuntherapie und personalisierte Behandlung bei Multipler Sklerose. Der Nervenarzt. 92(10). 986–995. 3 indexed citations
5.
Cieplik, Fabian, Karl‐Anton Hiller, Andreas Hiergeist, et al.. (2020). Oral Health, Oral Microbiota, and Incidence of Stroke-Associated Pneumonia—A Prospective Observational Study. Frontiers in Neurology. 11. 528056–528056. 31 indexed citations
6.
Utz, Kathrin S., et al.. (2020). Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?. Journal of the Neurological Sciences. 419. 117169–117169. 2 indexed citations
7.
Linker, Ralf A. & Andrew Chan. (2019). Navigating choice in multiple sclerosis management. SHILAP Revista de lepidopterología. 1(1). 5–5. 12 indexed citations
8.
Winder, Klemens, Ralf A. Linker, Konstantin Huhn, et al.. (2018). Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis. Journal of Neurology. 265(10). 2277–2283. 6 indexed citations
9.
Winder, Klemens, Ralf A. Linker, Frank Seifert, et al.. (2018). Insular multiple sclerosis lesions are associated with erectile dysfunction. Journal of Neurology. 265(4). 783–792. 20 indexed citations
10.
Scholz, Claus Jürgen, Stefanie Jörg, Ralf A. Linker, et al.. (2017). Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis. Proceedings of the National Academy of Sciences. 114(16). E3295–E3304. 52 indexed citations
11.
Schmidt, Manuel, Ralf A. Linker, Stefan Lang, et al.. (2017). FLAIRfusion Processing with Contrast Inversion. Clinical Neuroradiology. 28(3). 367–376. 9 indexed citations
12.
13.
14.
Domenig, Oliver, Arndt Manzel, Nadja Grobe, et al.. (2016). Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Scientific Reports. 6(1). 33678–33678. 70 indexed citations
15.
Manzel, Arndt, Oliver Domenig, Ágnes Zsófia Kovács, et al.. (2014). Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease. Journal of Neuroimmune Pharmacology. 9(4). 533–543. 2 indexed citations
16.
Linker, Ralf A., et al.. (2013). Advancing therapeutic options in multiple sclerosis with neuroprotective properties. Journal of Neural Transmission. 120(S1). 49–53. 5 indexed citations
17.
Haas, Jürgen, et al.. (2012). Fingolimod-Compassionate-use-Programm. Der Nervenarzt. 83(12). 1575–1581. 1 indexed citations
18.
Thöne, Jan, et al.. (2011). Inflammation modulates anxiety in an animal model of multiple sclerosis. Behavioural Brain Research. 220(1). 20–29. 75 indexed citations
19.
Kaltschmidt, Barbara, Ralf A. Linker, Jinbo Deng, & Christian Kaltschmidt. (2002). Cyclooxygenase-2 is a neuronal target gene of NF-κB. BMC Molecular Biology. 3(1). 16–16. 93 indexed citations
20.
Linker, Ralf A., Patrick A. Baeuerle, & Christian Kaltschmidt. (1996). Cloning of the murine relA (p65 NF-κB) gene and comparison to the human gene reveals a distinct first intron. Gene. 176(1-2). 119–124. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by De-Hyung Lee Breakdown of academic impact, for papers by Liqun Yang Breakdown of academic impact, for papers by Marjan Gharagozloo Breakdown of academic impact, for papers by Magnus Andersson Breakdown of academic impact, for papers by Hideto Yonekura Breakdown of academic impact, for papers by Takuo Watanabe Breakdown of academic impact, for papers by Lucia Lisi Breakdown of academic impact, for papers by Abdullah Al Mamun Breakdown of academic impact, for papers by Mark A. Lovell Breakdown of academic impact, for papers by Osman Yılmaz
Rankless by CCL
2026